Nestmedic S.A. (WSE:NST)
Poland · Delayed Price · Currency is PLN 0.7280
-0.0100 (-1.36%)
At close: Jul 3, 2026
Nestmedic Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.15 | 0.85 | 0.97 | 1.55 | 1.87 | 0.65 | |
Revenue Growth (YoY) | 51.63% | -12.67% | -37.39% | -17.08% | 185.23% | 76.44% |
Cost of Revenue | 0.22 | 0.2 | 0.31 | 0.6 | 1.06 | 0.56 |
Gross Profit | 0.93 | 0.64 | 0.65 | 0.95 | 0.81 | 0.1 |
Selling, General & Admin | 4.15 | 3.67 | 4.65 | 6.43 | 6.63 | 3.65 |
Other Operating Expenses | -0.09 | 0.15 | 0.01 | 0.29 | 0.51 | 0.08 |
Operating Expenses | 5 | 4.77 | 5.7 | 7.27 | 7.52 | 3.92 |
Operating Income | -4.07 | -4.13 | -5.05 | -6.32 | -6.71 | -3.82 |
Interest Expense | -0.18 | -0.25 | -0.22 | -0.41 | -0.31 | -0.37 |
Interest & Investment Income | - | 0.01 | 0.03 | 0.03 | 0 | 0.05 |
Other Non Operating Income (Expenses) | -0.18 | -0.16 | -0.07 | -0.09 | 0.01 | -0.04 |
EBT Excluding Unusual Items | -4.42 | -4.52 | -5.3 | -6.8 | -7.01 | -4.18 |
Gain (Loss) on Sale of Investments | 0 | - | - | -0 | - | - |
Asset Writedown | 0.07 | -0.08 | -0.08 | 0.03 | 2.06 | 0.28 |
Pretax Income | -4.35 | -4.6 | -5.38 | -6.77 | -4.95 | -3.91 |
Net Income | -4.35 | -4.6 | -5.38 | -6.77 | -4.95 | -3.91 |
Net Income to Common | -4.35 | -4.6 | -5.38 | -6.77 | -4.95 | -3.91 |
Shares Outstanding (Basic) | 43 | 39 | 27 | 25 | 19 | 10 |
Shares Outstanding (Diluted) | 43 | 39 | 27 | 25 | 19 | 10 |
Shares Change (YoY) | 49.57% | 41.86% | 10.64% | 31.02% | 86.94% | 39.63% |
EPS (Basic) | -0.10 | -0.12 | -0.20 | -0.27 | -0.26 | -0.39 |
EPS (Diluted) | -0.10 | -0.12 | -0.20 | -0.27 | -0.26 | -0.39 |
Free Cash Flow | -8.19 | -7.27 | -4.31 | -6.68 | -8.37 | -8.07 |
Free Cash Flow Per Share | -0.19 | -0.19 | -0.16 | -0.27 | -0.45 | -0.80 |
Gross Margin | 80.66% | 75.80% | 67.56% | 61.51% | 43.36% | 14.61% |
Operating Margin | -352.61% | -487.47% | -520.86% | -408.12% | -359.46% | -583.99% |
Profit Margin | -377.06% | -543.36% | -555.11% | -437.32% | -265.30% | -596.66% |
Free Cash Flow Margin | -710.20% | -858.58% | -444.67% | -431.65% | -448.14% | -1233.14% |
EBITDA | -3.12 | -4 | -4 | -5.76 | -6.33 | -3.6 |
D&A For EBITDA | 0.94 | 0.13 | 1.05 | 0.55 | 0.38 | 0.22 |
EBIT | -4.07 | -4.13 | -5.05 | -6.32 | -6.71 | -3.82 |
Revenue as Reported | 1.15 | 0.85 | 0.97 | 1.55 | 1.87 | 0.65 |